Cutting cost and time – HCV immunoassay predicts clinical response rate to antiviral treatment
Cutting cost and time – HCV immunoassay predicts clinical response rate to antiviral treatment
- Antiviral drugs for HCV are effective but expensive
- Immunoassay can predict response to antiviral drugs
- Significant reduction of long-term treatment cost
